Linkedin Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.

Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.

Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.

Webinar presenter Jeffrey Gregg, MD, University of Nevada

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.

Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Manage Subscription

To receive CAP TODAY magazine, please subscribe here.
For change of address, mail new information to: CAP TODAY Circulation, 325 Waukegan Road, Northfield, IL 60093-2750 or visit here.

Marketplace Directory

High-performance centrifuge system, 7/14

July 2014—Designed to improve productivity and ensure sample safety and integrity, the Thermo Scientific Sorvall RC BIOS 10 centrifuge system accommodates a range of cell culture and bioprocessing applications. The company’s Fiberlite F5-10×1000 LEX carbon fiber rotor spins up to 10 one-liter Nalgene centrifuge bottles in a single run. The system’s large capacity and design suits numerous applications, including bacterial and mammalian cell pelleting, pelleting of cell cultures from fermentation tanks, large microbial cultures, biologics and vaccine production, clarifying broths, and harvesting cell and tissue cultures.

Handheld label printer, 7/14

July 2014—Combining a tough exterior with smart printing capabilities, Brady’s BMP21-LAB handheld printer is designed for labeling slides, straws, dishware, bottles, vials, and tubes. The printer’s drop, lock, and print technology enables users to insert the label cartridge and start printing, with no setup required. The vial label shortcut key automatically cuts labels according to vial and tube sizes. Once the label is printed and cut, the grabber feature prevents it from falling to the ground.

Blood culture identification panel, 7/14

July 2014—The FilmArray BCID Panel M235 from Maine Molecular Quality Controls is for in vitro use as a quality control to monitor the detection and identification of 24 pathogens and three antibiotic-resistance genes associated with bloodstream infections when tested by the FilmArray Blood Culture Identification Panel. The kit contains 12 tubes, 100 µL each, of synthetic DNA suspended in a noninfectious solution of buffers, preservatives, and stabilizers and should be stored at 2°–8°C.

Copan and MetaSystems’ global partnership, 7/14

July 2014—Copan and MetaSystems signed a global and exclusive agreement for the integration of an automatic microscopy slide scanning system, provided by MetaSystems, with WASPLab. The partnership provides Copan customers a fully automated system for the acquisition of microscopy images of Gram slides (under the brand Metafer) integrated with the WASPLab environment.

New molecular methods standards, 7/14

July 2014—The Clinical and Laboratory Standards Institute released Nucleic Acid Sequencing Methods in Diagnostic Laboratory Medicine; Approved Guideline—Second Edition (MM09-A2) and published a new document, Microarrays for Diagnosis and Monitoring of Infectious Diseases; Approved Guideline (MM22-A). 


Combined urinalysis control, 6/14

June 2014—Streck introduced UA-Cellular Complete, a urinalysis control with both chemistry analytes and cellular components to more closely mimic a patient sample.

Rapid HIV tests, 6/14

June 2014—Chembio will begin marketing and selling the FDA-approved and CLIA-waived Chembio HIV 1/2 STAT-PAK assay in the U.S. market.

Beckman Coulter to acquire Xitogen, 6/14

June 2014—Beckman Coulter entered into an agreement to acquire Xitogen Technologies together with Cytojene Corp. Xitogen, a flow cytometer developer based in Suzhou and Dalian, China, will provide Beckman Coulter Life Sciences with an operational base in the China market, and the facilities in Suzhou and Dalian will function as research and development and manufacturing centers.

Influenza type A and B kit, 6/14

June 2014—The Poly stat Flu A & B kit from Polymedco is an in vitro, rapid qualitative test that detects influenza type A and B, including numerous strains of H1N1, directly from a nasal or nasopharyngeal swab, as well as nasopharyngeal aspirate/wash specimens.

Molecular subtyping with Agendia tests, 6/14

June 2014—Research presented at the annual conference of the American Society of Breast Surgeons in May reported that molecular subtyping using Agendia’s MammaPrint and BluePrint tests can provide guidance about whether to propose neoadjuvant treatment and what kind of treatment to recommend.

MARKETPLACE

TRENDING